RxDoctor Payments Data

Heidi Obrien, PA

Physician Assistant · Milford, MANPI 1417057944

Payments from drug & device makers

$1,330in general payments, 2019–2025

Across 52 payments — averaging $25.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tolmar, Inc.$235
  • Antares Pharma, Inc.$146
  • AbbVie$121
  • Astellas Pharma US Inc$119
  • Halozyme Inc$85
  • 180 Medical, Inc.$79
  • plus $546 from 14 others

What the payments were for

  • Food & beverage$1,26595%
  • Education$655%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,330 in reported general payments places this provider in the 90th percentile of 3,507 physician assistant providers in Massachusetts.

See all physician assistant providers in Massachusetts

Medicare billing

Part B allowed, 2024
$48,523
Medicare patients
315
Services billed
1,123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron257$197,152
MyrbetriqMirabegron297$196,913
Methenamine Hippurate235$17,186
Tamsulosin Hcl727$17,029
Mirabegron ErMirabegron46$15,063
Potassium Citrate ErPotassium Citrate130$12,373
Solifenacin Succinate200$12,310
Testosterone47$5,905
Cefpodoxime Proxetil139$5,532
Silodosin34$5,087
Dutasteride102$4,945
Oxybutynin Chloride ErOxybutynin Chloride118$4,454
Fesoterodine Fumarate ErFesoterodine Fumarate48$4,445
Finasteride226$3,662
Estradiol36$3,003

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$47$197,152257 claims
Astellas Pharma US IncMyrbetriq$119$196,913297 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,507 physician assistant providers in Massachusetts.

Other physician assistant in Milford

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →